JP2015517572A5 - - Google Patents

Download PDF

Info

Publication number
JP2015517572A5
JP2015517572A5 JP2015513993A JP2015513993A JP2015517572A5 JP 2015517572 A5 JP2015517572 A5 JP 2015517572A5 JP 2015513993 A JP2015513993 A JP 2015513993A JP 2015513993 A JP2015513993 A JP 2015513993A JP 2015517572 A5 JP2015517572 A5 JP 2015517572A5
Authority
JP
Japan
Prior art keywords
pyrido
indole
compound
ethoxy
fluoroethoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015513993A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015517572A (ja
JP5976206B2 (ja
Filing date
Publication date
Priority claimed from US13/477,095 external-priority patent/US8932557B2/en
Application filed filed Critical
Priority claimed from PCT/US2012/061912 external-priority patent/WO2013176698A1/en
Publication of JP2015517572A publication Critical patent/JP2015517572A/ja
Publication of JP2015517572A5 publication Critical patent/JP2015517572A5/ja
Application granted granted Critical
Publication of JP5976206B2 publication Critical patent/JP5976206B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015513993A 2012-05-22 2012-10-25 神経機能障害を検出するための造影剤 Active JP5976206B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/477,095 US8932557B2 (en) 2008-02-14 2012-05-22 Imaging agents for detecting neurological dysfunction
US13/477,095 2012-05-22
PCT/US2012/061912 WO2013176698A1 (en) 2012-05-22 2012-10-25 Carboline and carbazole based imaging agents for detecting neurological dysfunction

Publications (3)

Publication Number Publication Date
JP2015517572A JP2015517572A (ja) 2015-06-22
JP2015517572A5 true JP2015517572A5 (https=) 2015-10-15
JP5976206B2 JP5976206B2 (ja) 2016-08-23

Family

ID=47146722

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015513993A Active JP5976206B2 (ja) 2012-05-22 2012-10-25 神経機能障害を検出するための造影剤

Country Status (9)

Country Link
EP (1) EP2852572B1 (https=)
JP (1) JP5976206B2 (https=)
KR (1) KR101609504B1 (https=)
CN (2) CN107011342A (https=)
AU (1) AU2012381042B2 (https=)
CA (1) CA2873963C (https=)
CO (1) CO7131359A2 (https=)
ES (1) ES2792830T3 (https=)
WO (1) WO2013176698A1 (https=)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015110263A1 (en) * 2014-01-21 2015-07-30 Ac Immune Sa Carbazole and carboline compounds for use in the diagnosis, treatment, alleviation or prevention of disorders associated with amyloid or amyolid-like proteins
CA2946446C (en) * 2014-04-22 2020-11-03 Universite De Montreal Pyrido-pyrrolo-pyrimidine and pyrido-indole compounds, pharmaceutical compositions containing same and their use thereof in the expansion of hematopoietic stem cells and/or hematopoietic progenitor cells
RS61810B1 (sr) * 2014-05-13 2021-06-30 Hoffmann La Roche Deuterisana heterociklična jedinjenja i njihova upotreba kao sredstva za snimanje
US20180022748A1 (en) * 2015-02-02 2018-01-25 Ucb Biopharma Sprl 9h-pyrrolo-dipyridine derivatives
CN107207499A (zh) * 2015-03-04 2017-09-26 国立大学法人京都大学 经放射性碘标记的吡啶并[1,2‑a]苯并咪唑衍生物化合物
TW201707726A (zh) * 2015-08-19 2017-03-01 國立大學法人京都大學 放射性鹵素標誌吡啶并[1,2-a]苯并咪唑衍生物化合物
CA3003884C (en) 2015-11-13 2020-04-21 Eli Lilly And Company Azetidine derivatives for tau imaging
EP3487545A1 (en) 2016-07-22 2019-05-29 AC Immune S.A. Compounds for imaging tau protein aggregates
KR102472003B1 (ko) 2016-07-22 2022-11-29 에이씨 이뮨 에스에이 타우 단백질 응집체를 이미징하기 위한 화합물
WO2018024643A1 (en) 2016-08-02 2018-02-08 Ucb Biopharma Sprl 9h-pyrrolo-dipyridine derivatives
WO2018024642A1 (en) 2016-08-02 2018-02-08 Ucb Biopharma Sprl 9h-pyrrolo-dipyridine derivatives
IL290809B2 (en) * 2016-11-01 2024-01-01 Arvinas Operations Inc Tau-protein targeting protacs and associated methods of use
CN109884194A (zh) * 2017-12-06 2019-06-14 新疆维吾尔药业有限责任公司 一种药用植物的分离方法及其产品和应用
WO2019145291A1 (en) 2018-01-24 2019-08-01 Ac Immune Sa Gamma-carboline compounds for the detection of tau aggregates
WO2019145292A1 (en) 2018-01-24 2019-08-01 Ac Immune Sa Azacarboline compounds for the detection of tau aggregates
CN108409634B (zh) * 2018-05-10 2021-04-27 曲阜师范大学 咔唑类荧光胺类化合物标记试剂、合成和应用
EP3841100A1 (en) 2018-08-20 2021-06-30 Arvinas Operations, Inc. Proteolysis targeting chimeric (protac) compound with e3 ubiquitin ligase binding activity and targeting alpha-synuclein protein for treating neurodegenerative diseases
KR102215255B1 (ko) * 2019-06-12 2021-02-15 한국과학기술연구원 타우 응집체에 선택적으로 결합하는 형광 탐침자로서 유효한 신규 화합물 및 이의 제조 방법
CN119954801A (zh) 2019-07-17 2025-05-09 阿尔维纳斯运营股份有限公司 Tau蛋白靶向化合物及相关使用方法
US11618751B1 (en) 2022-03-25 2023-04-04 Ventus Therapeutics U.S., Inc. Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives
US11319319B1 (en) 2021-04-07 2022-05-03 Ventus Therapeutics U.S., Inc. Compounds for inhibiting NLRP3 and uses thereof
CN116003402B (zh) * 2021-11-02 2025-08-29 上海如絮生物科技有限公司 一种三环类化合物、其中间体、制备方法和应用
CN114539250B (zh) * 2022-03-04 2023-08-29 上海裕兰生物科技有限公司 一种阿尔兹海默症PET-tau示踪剂的制备方法
US12331048B2 (en) 2022-10-31 2025-06-17 Ventus Therapeutics U.S., Inc. Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors
JP2026504445A (ja) 2023-02-02 2026-02-05 イーライ リリー アンド カンパニー タウイメージングのための新規化合物
CN117050070B (zh) * 2023-07-05 2025-10-14 湘潭大学 一种荧光探针及其制备方法和在Aβ检测中的应用
WO2025155625A1 (en) 2024-01-16 2025-07-24 Eli Lilly And Company Novel compounds for tau imaging

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090170882A1 (en) * 2004-06-30 2009-07-02 Dashyant Dhanak Methods and compositions
FR2885905A1 (fr) * 2005-05-23 2006-11-24 Trophos Sa Nouveaux composes chimiques et leurs utilisations comme medicament
DE102006062203A1 (de) * 2006-12-22 2008-06-26 Curacyte Discovery Gmbh Substituierte 5H-Pyrimido[5,4-b]indole als Induktoren der Apoptose bei B-CLL Zellen
WO2008132454A1 (en) * 2007-04-26 2008-11-06 Ge Healthcare Limited Carbolines and their use as imaging agents
US20110046378A1 (en) * 2008-02-14 2011-02-24 Siemens Medical Solutions Usa, Inc. Novel Imaging Agents for Detecting Neurological Dysfunction
CA2731738A1 (en) * 2008-07-24 2010-01-28 Siemens Medical Solutions Usa, Inc. Imaging agents useful for identifying ad pathology
JP2012051804A (ja) * 2008-12-26 2012-03-15 Kyoto Univ Eg5阻害剤
US8691187B2 (en) * 2009-03-23 2014-04-08 Eli Lilly And Company Imaging agents for detecting neurological disorders
CN103739605B (zh) * 2009-03-23 2016-08-17 伊莱利利公司 用于检测神经障碍的显像剂
US10639608B2 (en) * 2010-04-08 2020-05-05 Siemens Medical Solutions Usa, Inc. System, device and method for preparing tracers and transferring materials during radiosynthesis
JP5585382B2 (ja) * 2010-10-22 2014-09-10 コニカミノルタ株式会社 有機エレクトロルミネッセンス素子、照明装置及び表示装置

Similar Documents

Publication Publication Date Title
JP2015517572A5 (https=)
JP2013014622A5 (https=)
BRPI1014595A2 (pt) procedimento de obtenção de novos derivados naftaleno para o diagnóstico in vivo de doença de alzheimer
WO2015191506A3 (en) Pyrrolo[2,3-c]pyridines as imaging agents for neurofibrilary tangles
JP2010529118A5 (https=)
HRP20230861T1 (hr) PROTUTIJELA PROTIV PEPTIDA N3pGLU AMILOIDA BETA I NJIHOVA UPOTREBA
JP2013525444A5 (https=)
ECSP088645A (es) Nuevos benzotiazoles sustituidos con heteroaril
JP2012255026A5 (https=)
JP2013528180A5 (https=)
JP2011507613A5 (https=)
JP2007527914A5 (https=)
JP2011522816A5 (https=)
JP2009545527A5 (https=)
JP2015511609A5 (https=)
HUE041616T2 (hu) Indocianin vegyület, szintézisének eljárása, tisztítási eljárása, indocianin vegyületet alkalmazó diagnosztikai készítmény, és készülék in vivo kinetika mérésére és készülék keringés megjelenítésére a diagnosztikai készítmény alkalmazásával
EP2198292A4 (en) IMPROVED MORBUS ALZHEIMER DIAGNOSIS
JP2019516739A5 (https=)
FR2965484B1 (fr) Utilisation de nanoparticules metalliques dans le diagnostic de la maladie d'alzheimer
BRPI0814339A2 (pt) composição farmacêutica, kit para a preparação da composição farmacêutica, conjugado, e, métodos de formação de imagem óptica in vivo do corpo de mamíferos, e de detecção, estabilização, diagnóstico, monitoramento do progresso da doença ou monitoramento do tratamento de um estado doentio do corpon dos mamíferos
JP2019535760A5 (ja) ガボキサドールを用いた注意欠陥多動性障害(adhd)の治療方法
JP2012516348A5 (https=)
MX2009009469A (es) Nuevos benzotiofenos y benzofuranos sustituidos en la posicion 2 con heteroarilo 709.
CO6341628A2 (es) \\\\\\\"nuevos compuestos adecuados como precursores de compuestos que son utiles para obtener imegenes de depositos amiloides\\\\\\\"
JP2012521353A5 (https=)